NCT01344057 Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012 Status COMPLETED Phase PHASE2
NCT01342796 Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects Status COMPLETED Phase PHASE2
NCT01209780 Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age Status COMPLETED Phase PHASE3
NCT01207232 The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates Status COMPLETED Phase NA
NCT01180621 Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children Status COMPLETED Phase PHASE2
NCT01161264 Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects Status COMPLETED Phase PHASE3
NCT01152814 Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011 Status COMPLETED Phase PHASE2
NCT01151059 Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects Status COMPLETED Phase PHASE2
NCT01147081 Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011 Status COMPLETED Phase PHASE3
NCT01123954 Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers Status COMPLETED Phase PHASE2
NCT01072799 Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine Status COMPLETED Phase PHASE2
NCT01011582 Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza Status COMPLETED Phase N/A
NCT00958776 A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza Status TERMINATED Phase PHASE3
NCT00957996 Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Status COMPLETED Phase PHASE3
NCT00956761 Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010 Status COMPLETED Phase PHASE2
NCT00956449 Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects Status COMPLETED Phase PHASE2
NCT00945841 Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010 Status COMPLETED Phase PHASE3